Enalapril Maleate
Product Images NDC 53002-2008

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Enalapril Maleate (NDC 53002-2008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 01)

Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 01)
Chemical structure of Enalapril maleate, showing its molecular components including aromatic ring, ethyl ester, secondary amine, and carboxylic acid groups.*
FDA Label Image

Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 02)

Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 02)
A data table comparing the incidence and discontinuation rates of various adverse effects for Enalapril maleate (n=573) versus placebo (n=339). The table categorizes effects by system such as Body as a Whole, Cardiovascular, Digestive, Nervous/Psychiatric, Respiratory, Skin, and Urogenital, listing symptoms like orthostatic effects, syncope, hypotension, diarrhea, dizziness, cough, rash, and urinary tract infection among others.*
FDA Label Image

Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 03)

Image (37366051 Ccb9 4ce6 9060 0d4fa9e00a66 03)
A data table showing initial dose recommendations of Enalapril maleate based on renal status and creatinine clearance levels. It includes dosages for normal renal function, mild impairment, moderate to severe impairment, and dialysis patients, with related footnotes about warnings and dosage adjustments on nondialysis days.*
FDA Label Image

Label Image (Lbl530022008)

Label Image (Lbl530022008)
Enalapril maleate 10 mg tablets packaging label by RPK Pharmaceuticals, Inc. The label indicates a bottle containing 30 tablets with instructions to take 1 tablet daily as directed. The label includes NDC 53002-2008, barcode, lot number, expiration date, and placeholders for clinic and patient information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.